[Watch original news]

Established in June 2014, AIDOT's Cerviray AI is an artificial intelligence-based cervical cancer remote reading system. Cerviray AI is equipped with CerviAID, an AI algorithm 

developed with AIDOT's proprietary technology. This system was developed through joint research with the two best hospitals in Korea, Seoul National University Bundang Hospital 

and the Obstetrics and Gynecology Department of Korea University Anam Hospital.

Over the past year, AIDOT has conducted joint ventures with several companies that provide large hospitals, examination centers, and medical facilities in China, and all of the joint 

venture companies have judged that AIDOT products are sufficient to enter the Chinese market. Currently, AIDOT is considering various methods to deploy the product in hospitals 

directly under the health authorities, 2nd and 3rd large hospitals, and examination centers.

AIDOT established a subsidiary in Beijing, China in 2017 and a China and Korean management's joint venture in Shenzhen, China in 2020. In addition to Cerviray AI products, AIDOT 

also has carotid ultrasound-based SONO dot AI system, pre-stroke diagnosis device NAO dot AI system, and GIGA dot AI system which capable of real-time diagnosis of digestive 

system. AIDOT is also currently developing an AI system to diagnose chronic alcoholic liver disease.

30th. Nov. 2021. / NEWSPIM / Reporter Ok-ham Joo